Updated on 22 October 2026
Digital Health, Patient Engagement & Care Pathways | Cluster Health 2027 Technology Partner
Innovation Unit Coordinator | EU Funding Manager at Datawizard Srl
Rome, Italy
About
Our contribution to Horizon Europe consortia includes:
-
Digital health platforms: patient applications, HCP dashboards, digital care pathways and remote monitoring solutions.
-
Patient engagement & empowerment: educational tools, personalised information, self-management services and PROMs/PREMs.
-
Co-design & UX/UI: patient journeys, accessibility, stakeholder involvement and user-centred design.
-
Clinical implementation: integration into healthcare pathways, pilot deployment, usability testing and validation.
Relevant experience: COMPASS (patient digital journey and empowerment platform), ProSalute 4.0 (post-cardiac event patient engagement) and MILIBRA (digital support for patients with bladder cancer).
Target Horizon Europe 2027 topics:
-
HORIZON-HLTH-2027-01-DISEASE-10
-
HORIZON-HLTH-2027-01-STAYHLTH-01
-
HORIZON-HLTH-2027-02-DISEASE-01
-
HORIZON-HLTH-2027-02-DISEASE-14
Collaboration sought: We aim to join consortia as a technology partner or leader of dedicated digital work packages/tasks, contributing to solution design, development, clinical integration and validation.
Topic
- Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
- Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Laura Zambelli
Grant Officer at IRCCS San Camillo Hospital
Venice, Italy
Project cooperation
Translational PET/CT and PET/MR imaging: from mouse models to patients
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
- Destination 5: HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Anastasios Gaitanis
Research Scientist, Level A' at Biomedical Research Foundation of the Academy of Athens
Athens, Greece
Project cooperation
Seeking Horizon Europe Consortia: Clinical Biomarker Validation, qPCR, ELISA and Cell-Based Research
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
- Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Duygu Eryavuz Onmaz
Associate Professor of Medical Biochemistry | Head of Department of Medical Biochemistry at Bandirma Onyedi Eylul Universty Faculty of Medicine
Balikesir, Türkiye